198 related articles for article (PubMed ID: 32935659)
21. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
Timsit JF; Mimoz O; Mourvillier B; Souweine B; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Lepape A; Vesin A; Arrault X; Schwebel C; Adrie C; Zahar JR; Ruckly S; Tournegros C; Lucet JC
Am J Respir Crit Care Med; 2012 Dec; 186(12):1272-8. PubMed ID: 23043083
[TBL] [Abstract][Full Text] [Related]
22. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
[TBL] [Abstract][Full Text] [Related]
23. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
[TBL] [Abstract][Full Text] [Related]
24. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
25. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
[TBL] [Abstract][Full Text] [Related]
26. Gauze and tape and transparent polyurethane dressings for central venous catheters.
Webster J; Gillies D; O'Riordan E; Sherriff KL; Rickard CM
Cochrane Database Syst Rev; 2011 Nov; (11):CD003827. PubMed ID: 22071809
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial on chlorhexidine dressings for the prevention of catheter-related bloodstream infections in neutropenic patients.
Biehl LM; Huth A; Panse J; Krämer C; Hentrich M; Engelhardt M; Schäfer-Eckart K; Kofla G; Kiehl M; Wendtner CM; Karthaus M; Ullmann AJ; Hellmich M; Christ H; Vehreschild MJ
Ann Oncol; 2016 Oct; 27(10):1916-22. PubMed ID: 27456299
[TBL] [Abstract][Full Text] [Related]
28. Dressings for the central venous catheter to prevent infection in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.
de Campos Pereira Silveira RC; Dos Reis PED; Ferreira EB; Braga FTMM; Galvão CM; Clark AM
Support Care Cancer; 2020 Feb; 28(2):425-438. PubMed ID: 31493134
[TBL] [Abstract][Full Text] [Related]
29. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
Crawford AG; Fuhr JP; Rao B
Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
[TBL] [Abstract][Full Text] [Related]
30. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
[TBL] [Abstract][Full Text] [Related]
31. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
[TBL] [Abstract][Full Text] [Related]
32. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
Jenks M; Craig J; Green W; Hewitt N; Arber M; Sims A
Appl Health Econ Health Policy; 2016 Apr; 14(2):135-49. PubMed ID: 26458938
[TBL] [Abstract][Full Text] [Related]
33. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
35. Use of a chlorhexidine-impregnated dressing reduced catheter-related bloodstream infections caused by Gram-positive microorganisms.
Ergul AB; Gokcek I; Ozcan A; Cetin S; Gultekin N; Torun YA
Pak J Med Sci; 2018; 34(2):347-351. PubMed ID: 29805406
[TBL] [Abstract][Full Text] [Related]
36. Biofilm Formation on Central Venous Catheters: A Pilot Study.
Niemann B; Dudas L; Gray D; Pettit A; Wilson A; Bardes JM
J Surg Res; 2022 Dec; 280():123-128. PubMed ID: 35964484
[TBL] [Abstract][Full Text] [Related]
37. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
[TBL] [Abstract][Full Text] [Related]
38. Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales.
Fraser C; Harron K; Dalton L; Gilbert R; Oddie SJ;
PLoS One; 2018; 13(11):e0204894. PubMed ID: 30383769
[TBL] [Abstract][Full Text] [Related]
39. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
[TBL] [Abstract][Full Text] [Related]
40. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Hockenhull JC; Dwan K; Boland A; Smith G; Bagust A; Dündar Y; Gamble C; McLeod C; Walley T; Dickson R
Health Technol Assess; 2008 Apr; 12(12):iii-iv, xi-xii, 1-154. PubMed ID: 18405471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
